Natural Grocers®, the nation's largest family-operated organic and natural grocery retailer, is adding two new, organic flavors to its beloved Natural Grocers® Brand Chocolate Bar selection: Dark ...

The Finnish BNPL market is poised for growth, driven by regulatory alignment with EU directives shifting towards regulated credit models. Key opportunities lie in enhancing bank-linked instalments, ...

Pfizer on Tuesday reported fourth-quarter profit above Wall Street estimates, as sustained demand for older drugs such as blood thinner Eliquis helped offset fading sales of its COVID ...

That has turned a spotlight on chipmaker AMD's after-hours earnings report, which should provide the best look yet at the AI trade amid those fears of Big Tech overspending and an ...

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the 10 Best AI Software Stocks to Buy Right Now. On January 22, Phillip Securities started covering Palantir Technologies Inc. (NASDAQ:PLTR), giving ...

Maplebear Inc. (NASDAQ:CART) ranks among the mid-cap stocks to buy according to top investors. Stifel reduced its price ...

The article says that OpenAI is trying to find more suppliers since the demand for high performance AI accelerators is growing quickly. Nvidia is still the best at making AI processors, but AMD has ...

Qualcomm (NASDAQ:QCOM) is set to post fiscal first-quarter results after the close on Wednesday, with investors watching demand trends across handsets, autos, and connected devices. Shares are down ...

Large, Finance and Markets Amid the dramatic twists and turns of the year so far, U. manufacturing seems to have rebounded ...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But as Peter Lynch said in One Up On Wall ...

Just four weeks after being sworn in as New York City’s mayor, Zohran Mamdani delivered a stark warning about the city’s finances — one he said rivals the worst downturn in recent memory. “I will be ...

Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street estimates as the loss of patent exclusivity on diabetes drug Januvia and other medicines will ...